¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"unsaturated vitamin B12 binding capacity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® vitamin ÇÑ±Û ºñŸ¹Î
¼³¸í   
  »ýü¿¡ ²À ÇÊ¿äÇÑ ¿µ¾çºÐÀÌÁö¸¸, ³»ºÎ¿¡¼­ ÇÕ¼ºµÇÁö ¾ÊÀ¸¹Ç·Î ¹Ýµå½Ã ¿ÜºÎ¿¡¼­ º¸ÃæÇؾ߸¸ µÇ´Â °ÍÀ» ¸»ÇÑ´Ù. ºÎÁ·½Ã »ý¸íÀ¯Áö°¡ ¾î·Á¿ì¸ç, Æ¯È÷ ÀϺΠºñŸ¹ÎÀº °ú´Ù½Ã¿¡µµ ÀÌ»óÀ» À¯¹ßÇϹǷΠÇ×»ó ÀûÁ¤¼öÁØÀ» À¯ÁöÇØ¾ß ÇÑ´Ù. ºñŸ¹Î A, D, E, K´Â Áö¿ë¼º ºñŸ¹ÎÀ¸·Î ÃàÀûÀÌ °¡´ÉÇϳª, ³ª¸ÓÁö´Â ¼ö¿ë¼ºÀ¸·Î ¸ÅÀÏ ¼·ÃëÇØ¾ß ÇÑ´Ù.
  
  ºñŸ¹Î B2(vitamin B2)
  
  RiboflavinÀ̶ó°íµµ ÇÔ. ÁַΠ¿ìÀ¯, Ä¡Áî, °è¶õ, °£, µî¿¡ ¸¹´Ù. ºÎÁ·½Ã ÀÔ¼úÁÖÀ§°¡ °¥¶óÁö´Â ÀÔ¼ú¿°, ÀÔ¼ú¾È¿¡ ¿°ÁõÀÌ »ý±â´Â ÀԾȿ°, ±×¸®°í °¢Á¾ ÇǺκ´ µîÀÌ ¹ß»ýÇÑ´Ù. ÁַΠ°¡³­ÇÑ ÈÄÁø±¹¿¡ ¸¹ÀÌ ¹ß»ýÇϸç, ÀϺΠ¿©¼º¿¡¼­ Áö³ªÄ£ ´ÙÀÌ¾îÆ®·Î ÀÎÇØ ¹ß»ýÇϱ⵵ ÇÑ´Ù.
  
  ºñŸ¹Î B6(vitamin B6)
  
  À̰ÍÀº pyridoxineÀ̶ó°íµµ ºÎ¸£¸ç pyridoxine, pyridoxal ¹× pyridoxamine ¼¼ °¡ÁöÀÇ È­ÇÕ¹°ÀÌ ÀÖ´Ù. À̵éÀº ¸ðµÎ Ã¼³»¿¡¼­ pyridoxal phosphate·Î È°¼ºÈ­µÇ¾î Á¶È¿¼Ò·Î ÀÛ¿ëÇÑ´Ù. À̴ ü³» ¾Æ¹Ì³ë»ê ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϴ Á¶È¿¼ÒÀÌ´Ù. ÀÌ ºñŸ¹ÎÀÌ °áÇ̵Ǹ頴ٹ߼º ¸»ÃʽŰ濰, ºóÇ÷ ¹× ÇǺκ´ÀÌ »ý±ä´Ù.
  
  
  
  ºñŸ¹Î B12(vitamin B12)
  
  ÀûÇ÷±¸ÀÇ »ý¼º¿¡ ÇʼöºÒ°¡°áÇÑ ºñŸ¹ÎÀÌ´Ù. ºÎÁ·½Ã Æ¯Â¡ÀûÀΠ´ëÀûÇ÷¸ð±¸)°¡ Ç÷¾×³»¿¡¼­ °üÂûµÈ´Ù. ´ëºÎºÐÀÇ ½Ä»çÇϴ ¹°Áú¿¡ µé¾îÀÖÀ¸¹Ç·Î ÀÎüÀÇ ³»ÀûÀÌ»óÀÌ ÀÖÁö ¾Ê°í´Â Àß ¹ß»ýÇÏÁö ¾Ê´Â´Ù. ´ëÇ¥ÀûÀΠ°æ¿ì°¡ ¾Ç¼ººóÇ÷·Î½á, ÀÌ ºñŸ¹ÎÀº À§¿¡¼­ ºÐºñµÇ´Â ³»ÀÎÀÚ(intrinsic factor)¿Í ÀÌÀÚÈ¿¼ÒÀÇ ÀÛ¿ëÀÌ ÀÖ¾î¾ß¸¸ Èí¼ö°¡ µÇ´Â µ¥, ¸¸¾à ¿©±â¿¡ ÀÌ»óÀÌ ÀÖÀ¸¸é Á¦´ë·Î Èí¼ö°¡ µÇÁö ¾ÊÀ¸¹Ç·Î Ç÷¾×³»¿¡ Á¤»óÀûÇ÷±¸ÀÇ °¨¼Ò¿Í °Å´ëÀûÇ÷±¸ÀÇ Áõ°¡°¡ ³ªÅ¸³ª, ºóÇ÷ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ºóÇ÷¿¡ ´ëÇÑ Áø´ÜÀº ½¯¸µ°Ë»ç(Schilling test)·Î½á °¡´ÉÇϸç, Ä¡·á´Â ºñŸ¹ÎÀÇ Åõ¿©ÀÌ´Ù.
  
  ºñŸ¹Î C(vitamin C)
  
  ÁַΠǪ¸¥ Ã¤¼Ò¿¡ ¸¹´Ù. ¿¾³¯¿¡ ¼­¾ç¿¡¼­ ¹è¸¦ Å¸°í Ç×ÇØÇÏ´ø »ç¶÷µé¿¡°Ô¼­ ÀÌÀ¯¸¦ ¾Ë ¼ö ¾ø´Â ÀæÀº ÃâÇ÷°ú ¸ÛÀ¸·Î ÀÚÁÖ »ç¸ÁÇϴ °æ¿ì°¡ »ý°Ü ±«Ç÷º´(scurvy)À̶ó°í ºÒ¸®¿ü´Ù. ³ªÁß¿¡ ±× ÀÌÀ¯°¡ Çª¸¥ Ã¤¼ÒÀÇ ¼·ÃëºÎÁ·À¸·Î ÀÎÇÑ ºñŸ¹ÎC °áÇÌÀΠ°ÍÀ» ¾Ë¾Ò´Ù. ÀÌ ºñŸ¹ÎÀº °áÇÕÁ¶Á÷ÀÇ Çü¼º¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇϹǷΠ¸¸¾à ºÎÁ·½Ã °áüÁ¶Á÷ÀÇ Çü¼ºÀÌ Á¦´ë·Î ÀϾÁö ¾Ê¾Æ Ç÷°üÀÌ ¼Õ»óµÇ¾î ÀæÀº ÃâÇ÷°ú ¸ÛÀÌ µé¸é Àß ³´Áö ¾Ê´Â Áõ»ó, ±×¸®°í °áÇÕÁ¶Á÷ÀÌ Àִ »À¿¡µµ ÀÌ»óÀÌ ¹ß»ýÇÑ´Ù. Ä¡·á´Â ºñŸ¹ÎÀÇ ¼·ÃëÀÌ´Ù.
  
  ºñŸ¹Î D(vitamin D)
  
  Ç÷ÁßÄ®½·³óµµÀÇ Á¶Àý¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. ÀÌ ºñŸ¹ÎÀº À§Ã¢ÀÚ°ü¿¡¼­ÀÇ Ä®½·Èí¼ö¸¦ ÃËÁøÇϰí, ¼Òº¯À¸·ÎÀÇ ¹è¼³À» °¨¼Ò½ÃÄÑ, Ç÷ÁßÄ®½·³óµµ¿Í Àλ꿰³óµµÀÇ Áõ°¡¸¦ °¡Á®¿Â´Ù. µû¶ó¼­ ¼Ò¾Æ±â¿¡¼­ °¨¼Ò½Ã »ÀÀÇ ¼ºÀåÀÌ ¾î·Æ°í, ½±°Ô ºÎ·¯Áö´Â °æÇâÀ» °¡Áö°í, ½ÉÇϸ頰öÃß°¡ µÇ´Â ±¸·çº´(rickets)ÀÌ ¹ß»ýÇÑ´Ù. ¼ºÀο¡¼­ °¨¼Ò½Ã¿¡´Â »ÀÀÇ Ä®½·³óµµ°¡ °¨¼ÒÇÏ¿© »ý±â´Â °ñ¿¬È­Áõ(osteomalacia)ÀÌ ¹ß»ýÇÑ´Ù. Ä¡·á´Â ºñŸ¹ÎÀÇ Åõ¿©ÀÌ´Ù.
  
  ºñŸ¹Î E(vitamin E)
  
  ÁַΠǪ¸¥ ÀÙÀ» °¡Áø Ã¤¼Ò¿Í ±Í¸®(wheat germ)¿¡ ¸¹´Ù. »ê¼Ò¿¡ ´ëÇÑ µ¶¼ºÀ» °¨¼Ò½Ã۴ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ¾î, »ê¼Òµ¶¼ºÀ¸·Î ¹ß»ýµÇ´Â °ÍÀ¸·Î ÃßÁ¤µÇ´Â ¹Ì¼÷¾Æ¸Á¸·ÁõÀÇ ¿¹¹æ¿¡ »ç¿ëµÈ´Ù. ¶ÇÇÑ ºÎÁ·½Ã ¿ëÇ÷ÀÌ ÀϾ´Ù.
  
  ºñŸ¹Î K(vitamin K)
  
  °£¿¡¼­ ¸¸µé¾îÁö´Â Ç÷¾×ÀÀ°í¹°ÁúÀÇ »ý¼º¿¡ ÇʼöÀûÀÌ´Ù. µû¶ó¼­ ºÎÁ·½Ã Ç÷¾×ÀÀ°í°¡ ÀÌ·ç¾îÁöÁö ¾Ê¾Æ Á¶±×¸¸ »óó¿¡µµ ÃâÇ÷°æÇâÀ» º¸ÀδÙ. ÁַΠ°£, Ã¤¼Ò±â¸§, ÀÙÀ» °¡Áø Ã¤¼Ò µî¿¡ ¸¹´Ù. ´ë°³ ºÎÁ·Àº ½Å»ý¾Æ¿¡°Ô¼­ ¸¹ÀÌ °üÂûµÈ´Ù.
¿µ¹® total lung capacity ÇÑ±Û ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
¼³¸í   
  ÆóȰ·®(°¡´ÉÇÑ ÇÑ ±í°Ô µé¿© ¸¶½Å ½ÃÁ¡ºÎÅ͠õõÈ÷ ÇѲ¯ ³»½® ¿ë·®)¿¡ Àܱⷮ(ÃÖ´ë ³¯¼ûÀ§Ä¡¿¡¼­ Æó³»¿¡ ³²Àº ¿ë·®. ¾à 1,200mL)À» ÇÕÇÑ °ÍÀÌ´Ù. °Ç°­ÇÑ ¼ºÀÎÀº 6,000~7,000mL. Æó±âÁ¾, ¸¸¼º ±â°üÁö¿° µîÀÇ Æó»ö¼º Àå¾Ö·Î Áõ°¡ÇϰԠµÇ´Â ÇÑÆí ÇãÆÄ¼¶À¯Áõ, ¹«±âÆó, Èä¼ö, Èä°ûº¯Çü µîÀÇ ±¸¼Ó¼º Àå¾Ö·Î °¨¼ÒÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • iron-binding capacity
    ö°áÇÕ´É
  • unsaturated compound
    ºÒÆ÷È­È­ÇÕ¹°
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • unsaturated hydrocarbon
    ºÒÆ÷ȭźȭ¼ö¼Ò
  • unsaturated solution
    ºÒÆ÷È­¾×
  • vitamin
    ºñŸ¹Î
  • vitamin A
    ºñŸ¹ÎA
  • vitamin D
    ºñŸ¹ÎD
  • vitamin D milk
    ºñŸ¹ÎD÷°¡¿ìÀ¯
  • vitamin D-dependent rickets
    ºñŸ¹ÎDÀÇÁ¸±¸·çº´
  • vitamin deficiency
    ºñŸ¹Î°áÇÌ(Áõ)
  • vitamin D-resistant rickets
    ºñŸ¹ÎDÀúÇ×±¸·çº´
  • vitamin E
    ºñŸ¹ÎE
  • vitamin K
    ºñŸ¹ÎK
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total iron binding capacity
    ÃÑö°áÇÕ´É
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • vitamin
    ºñŸ¹Î
  • binding
    ¹­À½, °áÇÕ
  • protein binding
    ´Ü¹é°áÇÕ
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • capacity
    ¿ë·®, ¾ç, ´É
  • adsorption capacity
    ÈíÂø´É
  • agglutinating capacity
    ÀÀÁý´É
  • bladder capacity
    ¹æ±¤¿ëÀû
  • buffering capacity
    ¿ÏÃæ´É
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • inspiratory capacity
    µé¼û¿ëÀû
  • predicted vital capacity
    ¿¹ÃøÆóȰ·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • iron-binding capacity
    ö°áÇÕ´É
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • unsaturated compound
    ºÒÆ÷È­È­ÇÕ¹°
  • unsaturated hydrocarbon
    ºÒÆ÷ȭźȭ¼ö¼Ò
  • unsaturated solution
    ºÒÆ÷È­¾×
  • vitamin deficiency
    ºñŸ¹Î°áÇÌ(Áõ)
  • vitamin D milk
    ºñŸ¹Îµð÷°¡¿ìÀ¯
  • vitamin requirement
    ºñŸ¹ÎÇʿ䷮
  • vitamin D-dependent rickets
    ºñŸ¹ÎµðÀÇÁ¸±¸·íº´
  • vitamin D-resistant rickets
    ºñŸ¹ÎµðÀúÇ×±¸·íº´
  • vitamin
    ºñŸ¹Î
  • antibody-binding site
    Ç×ü°áÇÕºÎÀ§
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • antigen binding receptor
    Ç׿ø°áÇÕ¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • UIBC => unsaturated iron binding capacity
    ºÒÆ÷ȭö°áÇÕ´É
  • IBC= iron binding capacity
    ö°áÇÕ´É.
  • TIBC => total iron binding capacity
    ÃÑö°áÇÕ´É
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • antihemorrhagic vitamin
    Ç×ÃâÇ÷¼º ºñŸ¹Î.
  • antipellagra vitamin
    Çׯç¶ó±×¶óºñŸ¹Î.
  • antirachitic vitamin
    Ç×±¸·çº´¼º ºñŸ¹Î.
  • high vitamin diet
    °íºñŸ¹Î½ÄÀÌ.
  • Forced expiratory vital capacity
    °­Á¦È£±âÆóȰ·®(Ë­ð¤û¼Ñ¨øËüÀÕá)
  • MBC=£¾maximum breathing capacity
    ÃÖ´ëÈ£Èí(¿ë)·®, ÃÖ´ëȯ±â·®.
  • TLC => total lung capacity
    ÀüÆó¿ë·®
  • VC => vital capacity
    ÆóȰ·®, Æó¸ð¼¼°ü Ç÷¾×·®
  • VC= vital capacity
    ÆóȰ·®, Æó¸ð¼¼°ü Ç÷¾×·®.
  • adsorption capacity
    ÈíÂø´É(ýåó·Òö).
  • agglutinating capacity
    ÀÀÁý´É
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unsaturated vitamin B12 binding capacity
    ºÒÆ÷È­ºñŸ¹Î B12 °áÇÕ´É
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unsaturated iron binding capacity
    ºÒÆ÷ȭö°áÇÕ´É(¡­ôÑÌ¿ùêÒö).
  • unsaturated iron binding capacity
    ºÒÆ÷ȭö°áÇÕ´É
  • vitamin B12
    ºñŸ¹Î B12
  • vitamin b12 deficiency
    ºñŸ¹ÎB12°áÇÌ(¡­ÌÀù¹)
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • iron binding capacity =IBC
    ö°áÇÕ´É(ôÑÌ¿ùêÒö).
  • iron-binding capacity
    ö°áÇÕ´É
  • total iron binding capacity
    ÃÑö°áÇÕ´É
  • total iron binding capacity=TIBC
    ÃÑö°áÇÕ´É
  • unsaturated
    ºÒÆ÷È­(ÝÕøéûú)ÀÇ.
  • unsaturated compound
    ºÒÆ÷È­È­ÇÕ¹°(¡­ûùùêÚª).[¾à¸®]ºÒÆ÷È­¹°.
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê (¡­ò·Û¸ß«).
  • unsaturated hydrocarbon
    ºÒÆ÷ȭźȭ¼ö¼Ò(ÝÕøéûú÷©ûýâ©áÈ).
  • unsaturated solution
    ºÒÆ÷È­¾×(¡­äû).
  • actin-binding protein
    ¾×ƾ °áÇմܹé(¡­Ì¿ùêÓ±ÛÜ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Vitamin deficiency (Fetal osteodystrophy)
    ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
    [¿¾ ¿ë¾î] ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unsaturated iron-binding capacity
    ºÒÆ÷È­(ÝÕøéûú) ö°áÇÕ´É(ôÑÌ¿ùêÒö)
  • vitamin B12
    ºñŸ¹Î B12
  • antigen binding capacity
    Ç׿ø °áÇÕ´É(ù÷ê«Ì¿ùêÒö)
  • latent iron-binding capacity
    ÀáÀçö°áÇÕ´É(íÖî¤ôÑÌ¿ùêÒö)
  • total iron-binding capacity
    ÃÑö°áÇÕ´É (õÅôÑÌ¿ùêÒö)
  • coenzyme B12
    "º¸È¿¼Ò(ÜÍý£áÈ) B12, (ÔÒ) cobamide"
  • unsaturated fatty acid
    ºÒÆ÷È­(ÝÕøéûú) Áö¹æ»ê(ò·Û¸ß«)
  • buffer capacity
    ¿ÏÃæ´É(èÐõúÒö)
  • carbon dioxide capacity
    Ç÷û ÀÌ»êȭź¼Ò(úìôèì£ß«ûù÷©áÈ) Çã¿ë·®(úÉé»Õá)
  • heat capacity
    ¿­¿ë·®(æðé»Õá)
  • anti-infective vitamin
    Ç×°¨¿°(ù÷Êïæø)ºñŸ¹Î
  • antidermatosis vitamin
    Ç×ÇǺο°(ù÷ù«Ý±¿°) ºñŸ¹Î
  • antihemorrhagic vitamin
    Ç×ÃâÇ÷¼º(ù÷õóúìàõ)ºñŸ¹Î
  • antirachitic vitamin
    Ç×±¸·çº´(ù÷±¸·çÜ») ºñŸ¹Î
  • B vitamin
    B-ºñŸ¹Î
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • binding
    ¹­À½, °áÇÕ
  • binding energy
    °áÇÕ¿¡³ÊÁö
  • vitamin
    ºñŸ¹Î
  • vitamin deficiency
    ºñŸ¹Î°áÇÌ(Áõ)
  • capacity
    ¿ë·®, ´É·Â, ¿ëÀû
  • respiratory capacity
    È£Èí¿ë·®, ÆóȰ·®
  • vital capacity
    ÆóȰ·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
UBBC unsaturated vitamin B12 binding capacity
UIBC unsaturated iron-binding capacity
IBC Institutional Biosafety Committee; iodine-binding capacity; iron-binding capacity; isobutyl cyanoacr...
VC color vision; variance cardiography; vascular changes; vasoconstriction; vena cava; venereal case; v...
B12 cyanocobalamin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
UBBC Unsaturated vitamin B12 binding capacity
VB12 Vitamin B12
UIBC unsaturated iron binding capacity
MUFA Mono-unsaturated
ufa Unsaturated fatty acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • serum vitamin B12
    Ç÷û ºñŸ¹Î B12
  • vitamin B12
    ºñŸ¹Î B12
    ½Ã¾Æ³ëÄڹ߶ó¹Î. Ç׺óÇ÷ ÀÎÀڷμ­ Àû»ö °áÁ¤. 4°³ÀÇ ÇÇ·Ñ ÇÙÀÇ 3°³ÀÇ Åº¼Ò ¿øÀÚ¿Í 6°³ÀÇ °ø¿ª ÀÌÁß °áÇÕÀ» Áö´Ñ ȯ»ó ±¸Á¶¸¦ ÀÌ·ç¸ç ÄÚ¹ßÆ®¸¦ Áö´Ñ´Ù. ½Ã¾È±â°¡ ÄÚ¹ßÆ®¿¡ ¹èÀ§°áÇÕÇØ ÀÖ´Ù. ºñŸ¹Î B12´Â ¼ö¿ë¼ºÀÌ¸ç ¾ËÄڿÿ¡ ¿ëÇØÇÏÁö¸¸ ¾Æ¼¼Åæ, ¿¡Å׸£¿¡´Â ³ìÁö ¾Ê´Â´Ù. »ê¿¡ ¾ÈÁ¤, ¾ËÄ®¸®¿¡´Â ºÒ¾ÈÁ¤ÇÏ´Ù. Co¿øÀÚ¿¡ °áÇÕÇÑ ½Ã¾È±â ´ë½Å¿¡ OH±â¶ó¸é ÇÏÀ̵å·Î¿Á½Ã Äڹ߶ó¹Î, CH3±â¶ó¸é ¸ÞÆ¿ Äڹ߶ó¹ÎÀ̶ó°í ÇÑ´Ù. ½Ã¾Æ³ë Äڹ߶ó¹Î ¼ö¿ë¾×Àº 278nm, 361nm, 548nm¿¡¼­ ÃÖ´ëÇÑ Èí¼öµÈ´Ù. ÀÌ ºñŸ¹ÎÀº Á¶Ç÷ ±â±¸¿¡ Áß¿äÇϸç, RNA¿¡¼­ DNAÀÇ Çü¼º ¹ÝÀÀ¿¡ °ü¿©ÇÑ´Ù°í »ý°¢µÈ´Ù. ½Ä»çÁßÀÇ ºñŸ¹Î B12´Â ¼ÒÀå Á¾¸»ºÎ¿¡¼­ Ä®½·, À§º®¿¡¼­ »ý»êµÇ´Â ³»ÀÎÀÚ ¹«ÄڴܹéÀÇ Á¸Àç ¾Æ·¡ Èí¼öµÈ´Ù. Ç÷û ¹Ý°¨±â´Â ¾à 1ÁÖÀÏÀÌ´Ù.
  • vitamin B12-intrinsic factor
    ºñŸ¹Î B12-³»Àμº ÀÎÀÚ
  • unsaturated compound
    ºÒÆ÷È­ È­ÇÕ¹°, ºÒÆ÷È­¹°
    ºÐÀÚ ¾È¿¡ ź¼Ò ¿øÀÚ »çÀÌÀÇ ÀÌÁß °áÇÕ ¶Ç´Â »ïÁß °áÇÕÀ» Æ÷ÇÔÇÏ´Â À¯±â È­ÇÕ¹°.
  • unsaturated hydrocarbon
    ºÒÆ÷È­ źȭ ¼ö¼Ò
    ź¼Ò°£ °áÇÕ¿¡¼­ ±Ëµµ Áßø¿¡ ÀÇÇØ »ý±â´Â ÆÄÀÌ ÀüÀÚ¶ó°í ÇÏ´Â 2~3½ÖÀÇ °øÀ¯ ÀüÀÚ¸¦ °®°íÀÖ´Â »óÅÂ. ÀÌ·± È­ÇÕ¹°Àº ºÒÆ÷È­ °áÇÕ¿øÀÚ¿¡ ÀüÀÚ±ºÀ», °áÇÕ´ÉÀÇ ÇѰè, Áï Æ÷È­±îÁö °áÇÕÀÌ °¡´ÉÇÏ´Ù.
  • unsaturated solution
    ºÒÆ÷È­ ¾×
  • agglutinating capacity
    ÀÀÁý´É
  • capacity coefficient
    ¿ë·® °è¼ö
  • cranial capacity
    µÎ°³³» ¿ë·®
  • diffusing capacity
    È®»ê´É, È®»ê¼º ´É·Â
    ÆóÀå¿¡ À־ °¡½º È®»ê´ÉÀ̶õ 1ºÐ µ¿¾È¿¡ 1 mmHgÀÇ ¾Ð·ÂÂ÷°¡ ÀÖÀ» ¶§ Àüü ÆóÆ÷ º®À» ÅëÇØ¼­ À̵¿ÇÏ´Â °¡½ºÀÇ ¾çÀÌ´Ù.
  • expiratory vital capacity
    È£½Ä ÆóȰ·®
  • forced vital capacity
    °­Á¦ ÆÐȰ·®, ³ë·Â¼º ÆóȰ·®, ³ë¼º ÆóȰ·®
  • functional residual capacity
    ±â´ÉÀû ÀÜ·ù ¿ë·®, ±â´ÉÀû Àܱⷮ
  • heat capacity
    ¿­ ¿ë·®
    ¾î¶² ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1 ¡É ³ôÀÌ´Â µ¥ ÇÊ¿äÇÑ ¿­·®. ¹°Ã¼ÀÇ ¿Âµµ°¡ ¾ó¸¶³ª ½±°Ô º¯ÇÏ´À³Ä¸¦ ³ªÅ¸³»´Â ¾çÀ¸·Î¼­ °¡·É ¿­ ¿ë·®ÀÌ Å« ¹°Ã¼´Â ¿Âµµ°¡ Àß º¯ÇÏÁö ¾Ê´Â ¹Ý¸é ¿­ ¿ë·®ÀÌ ÀÛÀº ¹°Ã¼´Â Á¶±Ý¸¸ ¿­À» °¡°¨Çصµ ½±°Ô ¿Âµµ º¯È­¸¦ ÀÏÀ¸Å°°Ô µÈ´Ù. ±× °ªÀº Áú·®¿¡ ºñ·ÊÇϸç, ´ÜÀ§ Áú·®ÀÇ ¿­ ¿ë·®Àº °¢ ¹°Áú °íÀ¯ÀÇ °ªÀ¸·Î ³ªÅ¸³ª´Âµ¥, À̰ÍÀ» ±× ¹°ÁúÀÇ ºñ¿­À̶ó°í ÇÑ´Ù. Áï ¾î¶² ¹°Ã¼ÀÇ ¿­ ¿ë·®Àº ºñ¿­°ú Áú·®À» °öÇÑ °ÍÀ̶ó ÇÒ ¼ö ÀÖ´Ù.
  • leukocyte bactericidal capacity test
    ¹éÇ÷±¸ »ì±Õ·Â °Ë»ç¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
vitamin B12 <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism.
(27 Sep 1997)
vitamin B12 absorption test <investigation> This test measures the amount of vitamin B12 in the urine after ingesting a dose of B12. This test evaluates vitamin B12 absorption. The cells in the stomach produce a substance known as intrinsic factor. This substance combines with B12 to allow absorption in the distal ileum. The patient is given a small dose of radioactive B12 which can then be detected in the patients urine. Pernicious anaemia is the clinical result of B12 deficiency. Conditions that can result in an abnormal Schilling test include: deficiency of intrinsic factor, malabsorption or the development of an antibody to intrinsic factor. The Schilling test can be performed with or without administration of intrinsic factor to determine what the underlying cause for pernicious anaemia. Laxative use, renal insufficiency and hypothyroidism can all interfere with the results of this test.
(27 Sep 1997)
vitamin B12 deficiency A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach).
(27 Sep 1997)
vitamin B12 neuropathy A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
vitamin B12 with intrinsic factor concentrate A combination of vitamin B12 with suitable preparations of the mucosa of the stomach or intestine of domestic animals used for food by humans.
(05 Mar 2000)
iron-binding capacity The capacity of iron-binding protein in serum (transferrin) to bind serum iron.
(05 Mar 2000)
total iron binding capacity <biochemistry, haematology> A test that measures indirectly the transferrin level in the bloodstream.
Transferrin is a protein that carries iron in the body. Normal values are 240 to 450 mcg/dl. This test is used to evaluate anaemia. Greater than normal total iron binding capacity can be seen in: iron deficiency anaemia, late pregnancy and polycythaemia vera.
Lower than normal total iron binding capacity can be seen in cirrhosis, sickle cell anaemia, hypoproteinaemia, pernicious anaemia and haemolytic anaemia. The use of birth control pills can lead to increased total iron binding capacity measurements.
Acronym: TIBC
(12 Jan 1998)
vitamin d-binding protein An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesised in the liver and carries vitamin d and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.
(12 Dec 1998)
fats, unsaturated Fats containing one or more double bonds, as from oleic acid, an unsaturated fatty acid.
(12 Dec 1998)
fatty acids, unsaturated Fatty acids containing one (monounsaturated) or multiple (polyunsaturated) double bonds. They predominate in most plant-derived fats. The number and position of each double bond can be specified, as in the systematic names, or the position of the double bond closest to the methyl group (omega) terminus can be specified to denote functional subdivisions of the overall group, e.g., omega-3 fatty acids. The numbers and positions of the double bonds have been linked to effects on plasma lipid, triglyceride, and cholesterol levels.
(12 Dec 1998)
unsaturated 1. Capable of absorbing or dissolving to a greater degree; as, an unsaturated solution.
2. <chemistry> Capable of taking up, or of uniting with, certain other elements or compounds, without the elimination of any side product; thus, aldehyde, ethylene, and ammonia are unsaturated.
Source: Websters Dictionary
(01 Mar 1998)
unsaturated alcohols Those alcohol's whose carbon chains contain one or more double or triple bonds.
(05 Mar 2000)
unsaturated fat <biochemistry> A fat that contains a carbon-carbon double bond, or a fat containing unsaturated fatty acids, such a fatty acid has double or triple covalent bonds and is thus able to add more atoms. Unsaturated fats are believed to lower blood cholesterol levels and are found at high levels in vegetable oils (olive oil, safflower oil, etc.) As a general rule, unsaturated fats are liquid at room temperature.
(09 Oct 1997)
unsaturated fatty acid <biochemistry> Fatty acid with one or more double bonds.
(18 Nov 1997)
coenzyme B12 <biochemistry> A coenzyme derived from cobalamine which is involved in carbon skeletal rearrangements. It is the only biomolecule known that has a carbon-metal bond.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unsaturated
    ÃæºÐÈ÷ ¿ëÇØµÇÁö ¾ÊÀº;Æ÷È­µÇÁö ¾ÊÀº;ºÒÆ÷È­ÀÇ
  • vitamin
    ºñŸ¹Î
  • vitamin(e)
    ºñŸ¹Î
  • binding
    Á¦º»
  • capacity
    ¿ë·®,¿ª·®,ÀÚ°Ý
  • Grolier binding(design)
    ±×·Ñ¸®¾î½Ä ÀåÁ¤(µðÀÚÀÎ)(±×´Â ±Ý½Ç·Î ¿«¾î ¸¸µç Àå½Ä)
  • binding
    ¹­´Â;µ¿ÀÌ´Â;Á¦º»;ºØ´ë;¼Ó¹Ú;¼Ó¹ÚÇÏ´Â
  • binding energy
    °áÇÕ¿¡³ÊÁö
  • breathing capacity
    ÆóȰ·®
  • capacity
    ¿ëÀû;¿ë·®;¿­(Àü±â)¿ë·®;(ÃÖ´ë)¼ö¿ë·Â(·®);Èí¼ö·Â;Æ÷¿ë·Â;Àç´É;¿ª·®;ÀÚ°Ý;ÀÔÀå;¹ýÀû ÀÚ°Ý;(°øÀåµîÀÇ)(ÃÖ´ë)»ý»ê ´É·Â;ÀÌÇØ·Â;ÇнÀ´É·Â;ÃÖ´ëÇÑÀÇ;²ËÂù;¸¸¿øÀÇ
  • carrying capacity
    ÀûÀç·®;(ÄÉÀ̺íÀÇ)¼ÛÀü·Â;(¸ñÃÊÁöµîÀÇ)µ¿¹° ºÎ¾ç ´É·Â
  • cloth binding
    (Ã¥ÀÇ)Ŭ·Î½ºÇ¥Áö(Á¦º»);Ŭ·Î½ºÀåÁ¤(º»)
  • deadweight capacity
    (ÇØ)ÀçÈ­ Áß·® Åæ¼ö
  • edition binding
    (Á¦º»)¹ÌÀå Á¦º»(Àå½ÄÀû üÁ¦¸¦ Áß¿ä½ÃÇÔ)
  • field capacity
    ³óÆ÷ ¿ë¼ö·®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á